Adjunctive cariprazine as a novel effective strategy for treating major depressive disorder: A systematic review and meta-analysis
M Xie, Y Qiu, M Wang, X Wei, Y Tao, A Duan… - Journal of Psychiatric …, 2024 - Elsevier
Background Cariprazine has been approved by the Food and Drug Administration for
treating bipolar depression and as an adjunctive treatment for Major Depressive Disorder …
treating bipolar depression and as an adjunctive treatment for Major Depressive Disorder …
Adjunctive Brexpiprazole for Patient Life Engagement in Major Depressive Disorder: A Canadian, Phase 4, Open-Label, Interventional Study: Brexpiprazole d'appoint …
F Therrien, C Ward, P Chokka… - The Canadian …, 2024 - journals.sagepub.com
Résumé Objectifs Caractériser les effets du brexpiprazole en traitement d'appoint sur
l'engagement dans la vie et les symptômes dépressifs chez les patients souffrant de trouble …
l'engagement dans la vie et les symptômes dépressifs chez les patients souffrant de trouble …